an integrated investor and public relations agency focused on advancing
health and science innovations, announced today it has won a Silver Bell
Ringer Award in the Investor/Financial Relations Campaign category from
Club of New England for the agency’s work on behalf of its client,
Ampio Pharmaceuticals (NYSE MKT: AMPE), a development stage
biopharmaceutical company focused on the discovery and development of
novel therapies aimed at treating common inflammatory conditions for
which there are limited treatment options.
LaVoieHealthScience developed an Investor/Financial Relations strategic
communications campaign to ensure on-message visibility for Ampio’s
announcement of pivotal data for Ampion™ for the treatment of
osteoarthritis of the knee.
The campaign included a press release that was offered to reporters on
an embargoed basis, as well as a post-distribution follow-on campaign
that targeted the full range of national, local, business, trade and
orthopedic outlets. In addition to the earned media, the campaign
included sponsored print and radio content. An important part of the
campaign also included a full suite of “infrastructure” including
detailed timelines and Q&A preparation.
“I want to thank our talented team and our client, Ampio for their
specialized thinking and spot-on execution on this important investor
communications program. We are honored to be recognized again in 2018 by
the Publicity Club of New England,” stated Donna L. LaVoie, President
Since 1969, the Publicity Club of New England’s Bell Ringer Awards have
been a symbol of outstanding achievement for New England public
relations and communications professionals in every field and industry
and across all forms of media.
LaVoieHealthScience partners with leading health and science brands to
build value for their companies, attract capital and reach key
stakeholders through integrated communications and marketing. The firm
provides strategic communications, investor relations and public
relations to build recognition and increase sales and value for health
science innovations. The agency has received over 30 awards over the
past seven years in recognition of the work it has done for its health
and science industry-leading clients and is ranked among the 2017 Inc.
5000 list of fastest growing private companies for the fourth year. In
addition to clients listed above, LaVoieHealthScience represents leaders
such as Affimed, BioAxone BioSciences, Biotechnology Innovation
Organization, Fusion Pharmaceuticals, Genosco, Landos Biopharma, LEO
Science Hub, Life Sciences Corridor, NewLink Genetics, Newron
Pharmaceuticals, Origenis GmbH, PathMaker Biosystems, Prescriber’s
Choice, Scioto Biosciences, Symbiotix, Triumvira Immunologics, Xontogeny
LLC, and other emerging health and science companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180618005920/en/